Hope for Endometrial Cancer: FDA Approves Durvalumab/Chemotherapy Combination for Hard-to-Treat Advanced Disease

      Fact Checked

      SurvivorNet Fact Checking and Medical Review Standards:  

      The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

      All SurvivorNet articles adhere to the following standards:

      1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
      2. When we use data, statistics, or quotes these references link to the original source.
      3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
      4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
      5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
      / Updated June 17th, 2024

      Hope for Endometrial Cancer: FDA Approves Durvalumab/Chemotherapy Combination for Hard-to-Treat Advanced Disease

      ×

      Introducing, the Journey Bar

      Use this bar to access information about the steps in your cancer journey.

      Please confirm you are a US based health care provider:

      Yes, I am a health care Provider No, I am not a health care provider